COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
申请人:Plexxikon Inc.
公开号:US20160176865A1
公开(公告)日:2016-06-23
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
本文描述了在蛋白激酶上活性化合物,以及使用这些化合物治疗与蛋白激酶异常活动相关的疾病和状况的方法。
PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
申请人:PLEXXIKON INC.
公开号:EP3088400A1
公开(公告)日:2016-11-02
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
[EN] SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS<br/>[FR] FORMES SOLIDES DE SULFONAMIDES ET D'ACIDES AMINÉS
申请人:PLEXXIKON INC
公开号:WO2010129570A1
公开(公告)日:2010-11-11
Solid forms of phenyl sulfonamide compounds of formula (I) active on protein kinases, including Raf protein kinases, are described, as well as methods of using such solid forms to treat diseases and conditions associated with activity of protein kinases, e.g. Raf protein kinases, including pain, polycystic kidney disease, melanoma and colorectal cancer.
Solid forms of phenyl sulfonamide compounds of formula (I) active on protein kinases, including Raf protein kinases, are described, as well as methods of using such solid forms to treat diseases and conditions associated with activity of protein kinases, e.g. Raf protein kinases, including pain, polycystic kidney disease, melanoma and colorectal cancer.